• Send Us A Tip
  • Calling all Tech Writers
  • Advertise
Friday, July 11, 2025
  • Login
TechStory
  • News
  • Crypto
  • Gadgets
  • Memes
  • Gaming
  • Cars
  • AI
  • Startups
  • Markets
  • How to
No Result
View All Result
  • News
  • Crypto
  • Gadgets
  • Memes
  • Gaming
  • Cars
  • AI
  • Startups
  • Markets
  • How to
No Result
View All Result
TechStory
No Result
View All Result
Home Business

Invictus Oncology A Biopharma Firm Acquires Funding From Tata

by Nitin Konde
February 8, 2016
in Business, News
Reading Time: 2 mins read
0
Invictus Oncology A Biopharma Firm Acquires Funding From Tata
TwitterWhatsappLinkedin

 

You might also like

Elon Musk’s xAI Unleashes Grok 4 and Unveils Premium $300/Month SuperGrok Heavy Subscription

Intel Embarks on Major Restructuring, Over 500 Employees Impacted in Initial Layoffs

OpenAI Plays ‘UNO Reverse,’ Poaches Top AI Talent from Meta and Other Rivals

Invictus

8 February, 2016, Delhi: Ratan Tata has been aggressively investing startups recently. Making its sixth investment in the row this year, Ratan Tata, chairman emeritus of Tata Sons has invested an undisclosed amount in Invictus Oncology Pvt. Ltd. in its series A Funding.

With this Ratan Tata had made his sixth investment in startups this year. Earlier he had invested in animal lovers’ portal Dogspot, coupons site CashKaro and baby products e-commerce site FirstCry.com, among others. He has been very aggressively investing in the startups and was among the most active angel investor last year.

Founded by R.A Mashelkar, former Director General, Council of Scientific and Industrial Research, and Shiladitya Sengupta, Harvard Medical School, It is a cancer therapeutics venture.

According to the WHO (World Health Organisation), 70 per cent of all cancer deaths occur in developing countries. Globally, India ranks third in terms of total new cancer cases occurring yearly. Cancer is also the second most common disease with about 0.3 million deaths per year. To this end, access to efficacious and affordable cancer drugs is still limited or nonexistent for most cancer patients in developing countries and thus, a diagnosis of cancer is synonymous to a death sentence.

Company aims to fight cancer by discovering novel, anti cancer therapeutics right here in India. It believes in the ‘treatment for all’ concept and aim to reach out to cancer patients from all sectors of society with innovative therapies at lower costs. This can be achieved if drug discovery and development takes place in India with the same benchmarks used in developed countries. Invictus Oncology strives to accelerate this by collaborative partnerships with organizations, hospitals and other key stakeholders.

Read: See more news articles on Ratan Tata’s investment in startups

Ratan Tata invests in B2B Marketplace Moglix

Ratan Tata Invests In India’s Largest Pet’s Portal DogSpot.in

Ratan Tata Shows Trust In Teabox

Tracxn Raises An Undisclosed Amount Of Funding From Ratan Tata

Ratan Tata Makes His Fourth Investment In Startup

Tags: CashkaroDogspotFirstCry.comHarvard Medical SchoolInvictus Oncology Pvt. Ltd.Ratan TataShiladitya SenguptaWHO
Tweet54SendShare15
Previous Post

Ratan Tata invests in B2B Marketplace Moglix

Next Post

Now Subscribe To Quik Heal ‘s Rs 451 Crore IPO; Subscription Opens Today

Nitin Konde

Recommended For You

Elon Musk’s xAI Unleashes Grok 4 and Unveils Premium $300/Month SuperGrok Heavy Subscription

by Anochie Esther
July 11, 2025
0
xAI

Elon Musk's artificial intelligence company, xAI, made a significant splash on Wednesday, July 9, 2025, with the simultaneous release of its latest flagship AI model, Grok 4, and...

Read more

Intel Embarks on Major Restructuring, Over 500 Employees Impacted in Initial Layoffs

by Anochie Esther
July 11, 2025
0
Intel

Intel, the venerable semiconductor giant, is undergoing a significant and painful restructuring effort, which includes substantial workforce reductions. While the company has not publicly disclosed the precise total...

Read more

OpenAI Plays ‘UNO Reverse,’ Poaches Top AI Talent from Meta and Other Rivals

by Anochie Esther
July 11, 2025
0
OpenAI

In a strategic move signaling a heating up of the AI talent war, OpenAI, the creator of ChatGPT, has reportedly begun poaching high-profile engineers from rival companies, including...

Read more
Next Post
Now Subscribe To Quik Heal ‘s Rs 451 Crore IPO; Subscription Opens Today

Now Subscribe To Quik Heal ‘s Rs 451 Crore IPO; Subscription Opens Today

Please login to join discussion

Techstory

Tech and Business News from around the world. Follow along for latest in the world of Tech, AI, Crypto, EVs, Business Personalities and more.
reach us at [email protected]

Advertise With Us

Reach out at - [email protected]

BROWSE BY TAG

#Crypto #howto 2024 acquisition AI amazon Apple bitcoin Business China cryptocurrency e-commerce electric vehicles Elon Musk Ethereum facebook flipkart funding Gaming Google India Instagram Investment ios iPhone IPO Market Markets Meta Microsoft News NFT samsung Social Media SpaceX startup startups tech technology Tesla TikTok trend trending twitter US

© 2024 Techstory.in

No Result
View All Result
  • News
  • Crypto
  • Gadgets
  • Memes
  • Gaming
  • Cars
  • AI
  • Startups
  • Markets
  • How to

© 2024 Techstory.in

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?